Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease [Phase 1]
A Phase Ib clinical trial evaluating combined febuxostat and inosine therapy for Parkinson's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
Vanderbilt University Medical Center is recruiting participants for a trial evaluating stereotactic radiosurgery to treat essential tremor a…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease [Phase 1]
This document reports an ongoing Phase 1 clinical trial evaluating autologous induced pluripotent stem cell-derived dopamine neurons transpl…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease [Phase 1]
A Phase 1 clinical trial is evaluating the safety and tolerability of XS411CN injection for primary Parkinson's disease and is currently rec…
-
EMA approval · 2025-09-10EMA Authorised: Tasmar (tolcapone) — Viatris Healthcare Limited
The European Medicines Agency authorised Tasmar (tolcapone) by Viatris Healthcare Limited for the treatment of Parkinson disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating the neuroprotective and symptomatic effects of silymarin in Parkinson's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Aim 3 Particle Swarm Optimization PIGD [NA]
Announces a recruiting clinical trial focused on Aim 3 Particle Swarm Optimization for Postural Instability and Gait Difficulty (PIGD) in Pa…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease [NA]
This entry describes a non-pharmacologic trial assessing scapulohumeral rehabilitation for improving scapula kinematics and upper-extremity …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Predicting Cognition After DBS for Parkinson's Disease 2
This clinical trial update centers on predicting cognitive outcomes after deep brain stimulation in Parkinson's disease and notes the study …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Parkinson's Disease Progression Study
Update on a Parkinson's disease progression clinical trial sponsored by Koneksa Health; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Gait Re-education Program in Subjects With Parkinson´s Disease [NA]
This clinical trial reports completion and posting of results for a gait re-education program in individuals with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: HIFT Training in People With Parkinson's Disease [NA]
This entry reports the completion of a clinical trial examining high-intensity functional training (HIFT) in people with Parkinson's disease…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Comparing Antipsychotic Medications in LBD Over Time [Phase 4]
A Phase 4 clinical trial comparing antipsychotic medications for Lewy body diseases is currently recruiting. The study is sponsored by The U…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: DBS of the MLR for Gait and Balance Disorders in PD Patients [NA]
A completed clinical trial evaluating deep brain stimulation of the mesencephalic locomotor region for gait and balance disorders in Parkins…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)
A clinical trial in Germany assessing the real-world effectiveness of the Foslevodopa/Foscarbidopa combination in adults at initial stages o…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants [Phase 1, Phase 2]
A double-blind Phase 1/2 trial evaluated the safety of glutamic acid decarboxylase gene transfer in Parkinson's disease. The study has compl…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease
A completed clinical trial evaluating how delayed feedback impacts non-motor symptoms in individuals with Parkinson's disease.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) [Phase 1, Phase 2]
This clinical trial update reports on an ongoing Phase 1/2 study (STEP) evaluating the safety, tolerability, and exploratory efficacy of EC5…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease [Phase 1]
Phase 1 clinical trial update indicates that PDR-001 is being studied to remove a harmful brain protein in Parkinson's disease and is curren…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes [Phase 2]
The study aims to evaluate the safety and efficacy of XJN010 nasal spray in patients with Parkinson's disease experiencing off episodes; the…
-
FDA approval · 2025-09-04FDA Approved: SELEGILINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Selegiline Hydrochloride from Chartwell RX, LLC, enabling the generic product's approval.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients [NA]
A completed clinical trial evaluating technology-assisted nudging to increase physical activity among hospitalized medical patients.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD [NA]
Clinical trial update examining the efficacy and mechanism of transcranial direct current stimulation for dysphagia in Parkinson's disease, …
-
CLINICAL_TRIALS other · 2025-09-04Clinical Trial Update: Microbiota Intervention to Change the Response of Parkinson's Disease [Phase 1, Phase 2]
The document reports that a UCSF-led Phase 1/Phase 2 clinical trial investigating a microbiota-based intervention for Parkinson's disease is…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status [NA]
This clinical trial is evaluating the Personal KinetiGraph device to improve insight into Parkinson disease status.